Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Mar 7, 2021; 27(9): 835-853
Published online Mar 7, 2021. doi: 10.3748/wjg.v27.i9.835
Table 2 Outcomes for 440 patients of coronavirus disease 2019, stratified by severity of cumulative liver abnormality or injury

All patients (n = 440)
Normal cumulative LB (n = 186)
Cumulative LBA (n = 185)
Cumulative ALI (n = 69)
Cumulative LBAI (n = 254)
P value1
Outcomes
Discharge304 (69.1)166 (54.6)117 (38.5)21 (6.9)138 (45.4)< 0.00012
Death98 (22.3)11 (11.2)45 (45.9)42 (42.9)87 (88.8)
Still in hospital38 (8.6)9 (23.7)23 (60.5)6 (15.8)29 (76.3)
ICU admission91 (20.7)11 (12.1)45 (49.5)35 (38.5)80 (88.0)< 0.0001
Time from illness onset to hospital admission (median, IQR), d43819 (11 to 35)13 (9 to 19)11 (8 to 16)12 (9 to 18)< 0.0001
Hospital stay time (median, IQR), d 40212 (6 to 22)19 (11 to 29)17 (8 to 28)19 (10 to 29)< 0.0001
Time from illness onset to death (median, IQR), d9319 (9 to 26)23 (16 to 33)28 (18 to 33)25 (17 to 33)0.037
Time from illness onset to discharge (median, IQR), d30340 (32 to 49)40 (34 to 51)42 (31 to 51)40 (34 to 50)0.088
Time from illness onset to last day of follow-up (median, IQR), d3761 (52 to 66)59 (49 to 64)58 (52 to 67)59 (51 to 65)0.689
Time from illness onset to ICU admission (median, IQR), d9015 (13 to 25)18 (11 to 30)19 (14 to 26)18 (12 to 26)0.478
Duration of viral shedding after illness onset (median, IQR), d29833 (24 to 42)30 (25 to 38)26 (21 to 36)30 (24 to 38)0.172